BN-107

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameBN-107

Drug Alias Nameanticancer therapeutics (Bionovo)VS-101 (Bionovo)BN-DI-110BN-EJ-111BN-SG-102 +[9]

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionApoptosis stimulantsSerine/threonine-protein kinase mTOR inhibitors

TargetsSerine/threonine-protein kinase mTOR

Therapy Area/IndicationsSolid tumoursBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBionovo Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBionovo Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursBreast Neoplasms

ATC CodeN/A